Oncomfort is a pioneering company in the realm of Digital Sedation™, a novel concept aimed at alleviating patients’ pain and anxiety without the use of medication. The company was born from a personal experience of its co-founder, Diane Jooris, who saw the need for non-pharmacological solutions in healthcare while caring for her sister battling breast cancer. This led to the creation of a medical device that combines virtual reality with clinical hypnosis to offer therapeutic sessions, proving beneficial in managing patient discomfort.

Jean-Philippe (JP) Allar, appointed as CEO in November 2022, brings his extensive experience from various executive roles in the medical device industry to Oncomfort. With over three decades in the field, Allar has a track record of establishing new therapies across global markets. His leadership is expected to guide Oncomfort through its global expansion and further the company’s mission in Digital Sedation™. JP Allar’s vision focuses on leveraging VR-based therapies in multidisciplinary symptom management, emphasizing the scale-up phase and beyond.

Digital sedation, as championed by Oncomfort, addresses the critical issue of managing pain and anxiety in medical settings without relying on pharmaceuticals. This approach is especially relevant in today’s healthcare landscape, where there is a growing emphasis on reducing medication use and finding alternative, effective methods for patient care.

The acquisition of Oncomfort by HypnoVR in October 2023 marked a significant development. HypnoVR, a leader in digital therapies for pain and anxiety management in Europe, aims to strengthen its position through this acquisition. HypnoVR’s technology, which has been adopted by over 550 European healthcare facilities, also utilizes VR to provide therapeutic sessions for pain and anxiety management. HypnoVR’s approach is validated by more than fifty clinical trials, underscoring the effectiveness of their therapies.

HypnoVR specializes in medical hypnosis through virtual reality, offering a unique multisensory immersive experience that reduces pain and stress with less medication. Their product is an ISO13485 certified medical device, designed by anaesthetists and hypnotherapists. The ease of use and accessibility of HypnoVR’s solutions are notable, allowing healthcare practitioners to initiate medical hypnosis sessions quickly and efficiently.

The synergy between Oncomfort’s expertise in Digital Sedation™ and HypnoVR’s established presence in digital therapies for pain and anxiety is poised to make a significant impact in healthcare. The combined strengths of these companies reflect a growing trend towards innovative, technology-driven solutions in medical care, particularly in the management of pain and anxiety without heavy reliance on pharmaceuticals.

Visit them at: https://www.oncomfort.com/en